PharmaPoint: Acute Coronary Syndrome - Current and Future Players


Naperville, IL -- (SBWIRE) -- 10/02/2014 -- Reportstack, provider of premium market research reports announces the addition of PharmaPoint: Acute Coronary Syndrome - Current and Future Players market report to its offering

PharmaPoint: Acute Coronary Syndrome - Current and Future Players


The publisher has released its pharma report, PharmaPoint: Acute Coronary Syndrome - Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing ACS Market. The report identifies and analyses the key companies shaping and driving the global ACS market. The report provides insight into the competitive ACS landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by team of industry experts.


- Investigation of current and future market competition for ACS
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of ACS sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving ACS market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- Whats the next big thing in the global ACS market landscape? Identify, understand and capitalize

Companies Mentioned

Bristol-Myers Squibb
Daiichi Sankyo
Eli Lilly
Janssen Pharmaceuticals (Johnson & Johnson)
The Medicines Company
Merck & Co.

To view the table of contents for this market research report please visit

Roger Campbell
United States
Ph: 888-789-6604